Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by SERB Pharmaceuticals
FDA has accepted a BLA for bentracimab, the first and only ticagrelor reversal agent, for filing and priority review
August 02, 2024
From
SERB Pharmaceuticals
Via
GlobeNewswire
SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million
July 31, 2024
From
SERB Pharmaceuticals
Via
GlobeNewswire
SERB Pharmaceuticals acquires Vistogard® and Xuriden® from Wellstat Therapeutics
July 13, 2023
From
SERB Pharmaceuticals
Via
GlobeNewswire
SERB Pharmaceuticals and SFJ Pharmaceuticals announce a U.S. partnership for bentracimab, a ticagrelor reversal agent
May 11, 2023
From
SERB Pharmaceuticals
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.